News | Avid Bioservices

Avid Bioservices to Participate in Morgan Stanley 20th Annual Global Healthcare Conference

Published on: September 7, 2022

TUSTIN, Calif.,Sept. 07, 2022(GLOBE NEWSWIRE) –Avid Bioservices, Inc.(NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve…

Avid Bioservices Appoints Pramthesh (Prem) Patel, Ph.D., as Vice President, Process Development for Mammalian Cell Business

Published on: September 1, 2022

Biopharmaceutical Executive with More than 30 Years of Experience With Top Global Big Pharma Companies GSK and Bristol Myers Squibb…

Avid Bioservices Announces Further Expansion of Process Development Capacity for Mammalian Cell Business

Published on: June 13, 2022

New Laboratories Have Potential to Support an Additional$20 Millionin Annual Process Development Revenue, Doubling Current Mammalian Cell Process Development Capacity…

Avid Bioservices to Participate in KeyBanc Capital Markets Life Sciences & MedTech Forum

Published on: March 16, 2022

TUSTIN, Calif.,March 16, 2022(GLOBE NEWSWIRE) –Avid Bioservices, Inc.(NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve…

Avid Bioservices Announces Official Opening of Second Downstream Processing Suite Within Myford North Facility

Published on: January 10, 2022

Milestone Marks Completion of First Phase of Two-Part Myford Facility Expansion; First Customer Project to Begin in New Downstream Processing…